NS

Nitin Sharma

Active Director Director DIN 11386064
DIN 11386064 First appointment Nov 2025 Primary industry Real Estate
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value •••• Premium profile

About Nitin Sharma

Data last updated:

Nitin Sharma is a Director at Medalvin Drugs Private Limited (since 2025). The company operates in Real Estate. Medalvin Drugs Private Limited reported revenue of ₹24 Lakh (FY 2025).

DIN 11386064
Primary Designation Director
Industry Real Estate
First Appointment 19 Nov 2025
Largest company Medalvin Drugs Private Limited · ₹24 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medalvin Drugs Private Limited U70200HR2023PTC109981
Director19 Nov 2025₹24 Lakh (FY 2025)Active

Board colleagues of Nitin Sharma

NameDINCompanyDesignation
Kunal Sharma11386096Medalvin Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medalvin Drugs Private Limited
Premium access

Shareholding and investment profile for Nitin Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Sharma

Nitin Sharma currently holds 1 directorship: Medalvin Drugs Private Limited (Director, since 19 Nov 2025, revenue ₹24 Lakh (FY 2025)).

Nitin Sharma was first appointed on 19 Nov 2025 as Director at Medalvin Drugs Private Limited.

The current boards of Nitin Sharma's companies include Kunal Sharma (Medalvin Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available